Brucellosis

The Silent Threat to Livestock and Human Health

Häftad, Engelska, 2025

2 249 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Brucellosis: The Silent Threat to Livestock and Human Health offers an in-depth look into the challenges posed by brucellosis, including its prevention, control, diagnosis, and treatment in animals and humans. This zoonotic disease is a significant concern not only for animal health but also public health, creating an economic burden worldwide. As the first comprehensive reference on brucellosis in decades, this book provides valuable insights into combating and managing the disease in herds and communities. The book emphasizes the importance of the One Health approach, presenting a global perspective on brucellosis.

In addition, it discusses the contagious nature of the disease and its impact on livestock and humans, particularly those working in animal husbandry. The book serves as a foundation for new research, highlighting the need for further studies due to the lack of a cure for animals and the difficulties in treating humans.

Reviews Brucellosis in cattle, goats, sheep, swine, and humans
Covers prevention, control, clinical presentation, and treatment
Presents diagnostic tools and techniques
Identifies zoonotic transmission, epidemiology, and global distribution
Includes case studies of outbreaks in both livestock and human populations
Explores Brucellosis in food safety and processing

Produktinformation

Utgivningsdatum2025-10-29
Mått216 x 276 x 28 mm
Vikt1 350 g
FormatHäftad
SpråkEngelska
Antal sidor498
FörlagElsevier Science
ISBN9780443300677

Tillhör följande kategorier

Veterinärmedicin inom Medicin
Patologi inom Medicin
Djurhållning inom Naturvetenskap och teknik

Maryam Dadar, DVM, PhD, is currently a researcher at the Veterinary Council of Iran, Tehran, Iran. She s an Assistant Professor in the Department of Brucellosis at the Razi Vaccine and Serum Research Institute in Iran. Her extensive expertise lies in the field of microbiology and molecular biology, with main areas of research in zoonotic diseases, microbial risk assessments, Brucellosis prevention and control, and One Health. She has published articles in numerous international journals, edited books including an Elsevier title on brucellosis, and serves as an editor and is on the editorial board of a number of journals such as Microbial Risk Analysis (Elsevier). Dr. Dadar actively participates in international, multidisciplinary research collaborations with colleagues in Germany, United Kingdom, United States, and Pakistan and in educational initiatives aimed at advancing the scientific foundations of zoonotic infections, veterinary science, and molecular medicine.

1. Historical context and background ofbrucellosis in the world2. Brucellosis throughout human history3. The genetic diversity of Brucella speciesPart II Pathogenesis and immunobiology of brucellosis4. Pathogenesis and immunopathological phenomena around Brucella infections 5. Immunopathology in osteoarticular Brucella infection Part IIIBrucellosis in animals6. Brucellosis in livestock and companion animals7. Brucellosis in dogs: epidemiology, diagnosis, and public health concerns8. Brucellosis in aquatic mammals Part IVZoonotic transmission10. Occupational exposure to Brucella spp. and risk behaviors in exposed professions11. Brucellosis in Tanzania and Rwanda: Current status, challenges, and control strategiesPart V Diagnostic tools and techniques12. Diagnostic tools and techniques for Brucella detection13. Pathology of brucellosis in livestock Part VI Clinical manifestations in humans14. Brucellosis: Clinical manifestations in humans15. Rare cases of human brucellosisPart VII Prevention and control in animals16. The science of brucellosis elimination 17. Brucellosis control, eradication, and prevention 18. Comprehensive strategies for brucellosis control in endemic areas19. Efficacy of Brucella vaccine strains: S19, RB51, and Rev-1Part VIII Prevention and control in humans20. Therapeutic advances in human brucellosis21. Medicinal plants used in the treatment of brucellosisPart IX One health approach22. Knowledge, attitudes, and practices (KAP) relating to brucellosis: Unveiling the vital role of public awareness23. One health approach to brucellosis in SE Europe Part X Emerging trends and future prospects24. Challenges posed by antibiotic resistance in human and animal brucellosis25. Antimicrobial resistance of Brucella melitensis Part XI Brucellosis in food safety and processing26. Brucellosis in food safety